एपीए उद्धरण

Dierynck, I., Van Marck, H., Van Ginderen, M., Jonckers, T. H. M., Nalam, M. N. L., Schiffer, C. A., . . . Picchio, G. (2011). TMC310911, a Novel Human Immunodeficiency Virus Type 1 Protease Inhibitor, Shows In Vitro an Improved Resistance Profile and Higher Genetic Barrier to Resistance Compared with Current Protease Inhibitors. American Society for Microbiology.

शिकागो स्टाइल उद्धरण

Dierynck, Inge, Herwig Van Marck, Marcia Van Ginderen, Tim H. M. Jonckers, Madhavi N. L. Nalam, Celia A. Schiffer, Araz Raoof, Guenter Kraus, और Gaston Picchio. TMC310911, a Novel Human Immunodeficiency Virus Type 1 Protease Inhibitor, Shows In Vitro an Improved Resistance Profile and Higher Genetic Barrier to Resistance Compared With Current Protease Inhibitors. American Society for Microbiology, 2011.

एमएलए उद्धरण

Dierynck, Inge, et al. TMC310911, a Novel Human Immunodeficiency Virus Type 1 Protease Inhibitor, Shows In Vitro an Improved Resistance Profile and Higher Genetic Barrier to Resistance Compared With Current Protease Inhibitors. American Society for Microbiology, 2011.

चेतावनी: ये उद्धरण हमेशा 100% सटीक नहीं हो सकते हैं.